Fundraising Fox

Trovagene

NASDAQ: CRDF

San Diego, US · Founded 1999 · Delaware corporation · 51 employees on LinkedIn · 1 known investors

Biotech

Founders & leadership

TA
Thomas AdamsExecutive
ASAntonius Schuh
Antonius SchuhinChief Executive Officer2011–2016
DR
David RobbinsinVice President, Research2006–2012
SZ
Steve ZanibobiExecutive

Board

GC
Gabriele CerroneBoard director
GJ
Gary JacobBoard director
JB
John BrancaccioBoard director
AC
Athena CountouriotisBoard director
RM
Rodney MarkinBoard director
ST
Stanley TennantBoard director

Investors · 1

ACORN BIOVENTURESreportedNew York

Reported raises · per SEC filings

Form D private placements

$35M disclosed across 9 of 10 rounds · 2009–2020

▶$13.5MraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary JacobDirector
  • Mark ErlanderExecutive Officer, Director
  • James O. ArmitageDirector
  • Lale WhiteDirector
  • Thomas AdamsDirector
  • Rodney S. MarkinDirector
  • John BrancaccioDirector
  • Gary W. PaceDirector
Offering amount
$13.5M
Amount sold
$13.5M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary JacobDirector
  • Thomas AdamsDirector
  • John BrancaccioDirector
  • Lale WhiteDirector
  • Mark ErlanderExecutive Officer
  • Gary W. PaceDirector
  • Rodney S. MarkinDirector
  • James O. ArmitageDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$810KraisedMay 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Adams, Ph.D.Director
  • Rodney MarkinDirector
  • Mark Erlander, Ph.D.Executive Officer
  • James ArmitageDirector
  • Gary Jacob, Ph.D.Director
  • Gary Pace, Ph.D.Director
  • John BrancaccioDirector
  • Lale WhiteDirector
Offering amount
$810K
Amount sold
$810K
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedApr 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rodney S. MarkinDirector
  • Mark ErlanderDirector
  • Thomas AdamsExecutive Officer, Director
  • John BrancaccioDirector
  • James O. ArmitageDirector
  • Lale WhiteDirector
  • Gary W. PaceDirector
  • Gary JacobDirector
Offering amount
$2.1M
Amount sold
$2.1M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedOct 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Athena CountouriotisDirector
  • Brigitte LindsayExecutive Officer
  • Rodney MarkinDirector
  • Gary S. JacobDirector
  • Thomas H. AdamsExecutive Officer, Director
  • John P. BrancaccioDirector
Offering amount
$5M
Amount sold
$5M
Sales commissions
$1.1M
Placement agents
H.C. Wainwright & Co., LLC
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Athena CountouriotisDirector
  • John BrancaccioDirector
  • Rodney S. MarkinDirector
  • Gary JacobDirector
  • Thomas AdamsExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMay 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rodney S. MarkinDirector
  • Athena CountouriotisDirector
  • Gary JacobDirector
  • John BrancaccioDirector
  • Thomas AdamsExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedApr 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary JacobDirector
  • Thomas AdamsExecutive Officer, Director
  • John BrancaccioDirector
  • Athena CountouriotisDirector
  • Rodney S. MarkinDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cardiff Oncology Raises $13.5M in Equity Funding | FinSMEsfinsmes.com · Jun 2020Trovagene Announces $1.5 Million Equity Investment at Premium to Market from Institutional Investor, Lincoln Park Capitalprnewswire.com · Apr 2019Trovagene raises $7m for precision cancer therapies - Drug Delivery Businessdrugdeliverybusiness.com · Jul 2017Spotlight On... Chase Pharma raises $12M for Alzheimer's R&D; Trovagene axes CEO, CFO for snatching a business 'opportunity'; Keryx lifted by late-stage anemia data; and more... | Fierce Biotechfiercebiotech.com · Mar 2016UPDATED: Trovagene raises $23M in follow-on share offering for urine-based cancer diagnostic | Fierce Biotechfiercebiotech.com · Feb 2015

Frequently asked questions

Who are Trovagene's investors?
Trovagene's investors include ACORN BIOVENTURES.
How much funding has Trovagene raised?
Trovagene has disclosed $35M raised across 9 of its 10 known rounds.
Where is Trovagene headquartered?
Trovagene is headquartered in San Diego, US.